ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,186 | +7.9% | 296 | 0.0% | 0.00% | – |
| Q2 2023 | $15,934 | +132683.3% | 296 | +2.1% | 0.00% | – |
| Q1 2023 | $12 | 0.0% | 290 | 0.0% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 290 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | +22.2% | 290 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | +12.5% | 290 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -86.9% | 290 | -80.8% | 0.00% | – |
| Q4 2021 | $61,000 | -3.2% | 1,510 | -20.9% | 0.00% | – |
| Q3 2021 | $63,000 | -10.0% | 1,910 | -5.0% | 0.00% | – |
| Q2 2021 | $70,000 | +366.7% | 2,010 | +390.2% | 0.00% | – |
| Q1 2021 | $15,000 | +25.0% | 410 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +300.0% | 410 | +272.7% | 0.00% | – |
| Q3 2020 | $3,000 | -25.0% | 110 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | -98.6% | 110 | -98.4% | 0.00% | -100.0% |
| Q1 2020 | $277,000 | -33.9% | 6,790 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $419,000 | +84.6% | 6,790 | +117.6% | 0.00% | +100.0% |
| Q3 2019 | $227,000 | -63.6% | 3,120 | -58.9% | 0.00% | -66.7% |
| Q2 2019 | $624,000 | +16.6% | 7,588 | 0.0% | 0.01% | +20.0% |
| Q1 2019 | $535,000 | +10600.0% | 7,588 | +6798.2% | 0.01% | – |
| Q4 2018 | $5,000 | -16.7% | 110 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -14.3% | 110 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | -96.4% | 110 | -96.3% | 0.00% | -100.0% |
| Q1 2018 | $192,000 | -4.0% | 3,010 | -3.2% | 0.00% | 0.0% |
| Q4 2017 | $200,000 | +22.7% | 3,110 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $163,000 | +19.9% | 3,110 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $136,000 | -11.7% | 3,110 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $154,000 | -59.0% | 3,110 | -49.8% | 0.00% | -60.0% |
| Q4 2016 | $376,000 | +77.4% | 6,200 | +93.8% | 0.01% | +66.7% |
| Q3 2016 | $212,000 | +18.4% | 3,200 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $179,000 | +65.7% | 3,200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $108,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |